financetom
Business
financetom
/
Business
/
Team Amends Asset-Based Lending Credit Facility
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Team Amends Asset-Based Lending Credit Facility
Oct 2, 2024 9:53 PM

05:45 PM EDT, 09/30/2024 (MT Newswires) -- Team (TISI) said late Monday it extended the maturity date of its existing asset-based lending credit facility through Sept. 30, 2027, from Aug. 11, 2025, among other changes.

The facility comprises a $130 million revolving credit facility and a $27.4 million term loan secured by certain real estate and machinery and equipment of the company, as well as a $35 million delayed draw term loan.

Team said the revolver's terms were amended to provide expanded availability based upon certain milestones.

The company shares were down 1.6% in after-hours activity.

Price: 15.00, Change: -0.25, Percent Change: -1.64

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Dominion Lending Centres Swings Back to a Fourth-Quarter Adjusted Profit on Improved Revenue
Dominion Lending Centres Swings Back to a Fourth-Quarter Adjusted Profit on Improved Revenue
Mar 19, 2024
05:29 PM EDT, 03/19/2024 (MT Newswires) -- Dominion Lending Centres (DLGC.TO) on Tuesday said it returned to a fourth-quarter adjusted profit on higher revenue. The mortgage lender reported an adjusted profit, which excludes most one-time items, of C$1.78 million, or C$0.04 per share, in the period, compared with and adjusted loss of C$0.18 million, or nil, in the year-prior quarter....
Corvus Pharmaceuticals to Start Phase 1 Study of Atopic Dermatitis Treatment in Q2
Corvus Pharmaceuticals to Start Phase 1 Study of Atopic Dermatitis Treatment in Q2
Mar 19, 2024
05:32 PM EDT, 03/19/2024 (MT Newswires) -- Corvus Pharmaceuticals ( CRVS ) said Tuesday it expects to start a phase 1 study of soquelitinib in patients with moderate to severe atopic dermatitis in Q2. Corvus expects to enroll 64 patients who have previously failed at least one therapy and compare four different doses of the drug with placebo for safety...
Mitek Systems Fiscal Q4 Non-GAAP Net Income, Revenue Decline, Reiterates Fiscal 2024 Outlook
Mitek Systems Fiscal Q4 Non-GAAP Net Income, Revenue Decline, Reiterates Fiscal 2024 Outlook
Mar 19, 2024
04:26 PM EDT, 03/19/2024 (MT Newswires) -- Mitek Systems ( MITK ) reported fiscal Q4 Non-GAAP net income Tuesday of $0.15 per diluted share, down from $0.22 a year ago. Revenue for the quarter ended Sept. 30 was $37.7 million, down from $39.6 million a year earlier. The company kept its fiscal 2024 revenue outlook in the range of $180...
Gambling.com Group Secures $50 Million Credit Facility
Gambling.com Group Secures $50 Million Credit Facility
Mar 19, 2024
05:28 PM EDT, 03/19/2024 (MT Newswires) -- Gambling.com Group ( GAMB ) said Tuesday it has secured a $50 million credit facility from Wells Fargo Bank, maturing on March 19, 2027. The new facility, consisting of a $25 million revolving credit facility and a $25 million term loan facility, may be increased by up to $10 million, subject to approval...
Copyright 2023-2026 - www.financetom.com All Rights Reserved